Intraoperative Vasopressin Injection During Hysteroscopic Myomectomy

Ferguson, James; Rattray, Darrien; Thiel, John; Weins, Laura

doi:10.1016/j.jmig.2016.08.461

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…reported another case of complete large intracavity myomectomy with vasopressin injection. [ 13 ] The existing literature confirms that with both intracervical and intralesional injection of dilute vasopressin, surgeons will be able to manage the bleeding and loss of fluid during myomectomy which leads to complete resection of myoma in one session. Here, in this study, we performed all resections in one session.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Effect of Vasopressin during Hysteroscopic Myomectomy in Patients with Submucosal Myoma

Rouholamin

Hashemi

Haghshenas

2021

Advanced Biomedical Research

View full text Add to dashboard Cite

Background: The aim was to assess the effect of vasopressin in reducing the time of surgery, amount of bleeding, and fluid deficit during hysteroscopic myomectomy of submucosal myoma from 2016 to 2018. Materials and methods: This study was conducted as a prospective, randomized, single-blinded clinical trial on the premenopausal women ranged from 18 to 62 years' old. A number of 80 patients were randomly assigned to each arm of the study according to random consecutive numbers. The control group ( n = 40) of patients underwent conventional hysteroscopic myomectomy without vasopressin and the case group ( n = 40) underwent hysteroscopic myomectomy with the injection of diluted vasopressin. Measured outcomes were time for myomectomy, fluid deficit, inflow volume, visual clarity, and postoperation hemoglobin level. Results: The mean time of myomectomy was 38.1 and 77.38 min in vasopressin and control groups, respectively ( P < 0.001). The mean inflow volume was 2800 and 4100 in vasopressin and control groups, respectively ( P = 0.029). The visual clarity score was 8.5 and 6.5 in the vasopressin and control groups, respectively ( P < 0.001). Conclusions: The injection of vasopressin during hysteroscopic myomectomy is effective in the management of fluid deficit, time of surgery, and improvement of visual clarity.

show abstract

Section: Discussionmentioning

confidence: 99%

“…[ 10 11 ] The management of blood loss during surgery reduces the operative time and improves the visual clarity. [ 12 13 14 ] The aim of the present study was to assess the effect of vasopressin in reducing the time of surgery, fluid deficit, visual clarity, and amount of bleeding.…”

Section: Introductionmentioning

confidence: 99%